Experts address COVID-19 vaccine myths, safety evidence, and how to frame the benefits of vaccination in pregnancy.
|Articles|July 17, 2012
Poll: Does Your Practice Sell Ancillary Products?
Author(s)OBGYN.net Staff
From nutritional supplements to pregnancy support products to spa services, more ObGyn practices--and physicians' offices in general--are turning to ancillary products as additional sources of revenue.
Advertisement
From nutritional supplements to pregnancy support products to spa services, more ObGyn practices--and physicians' offices in general--are turning to ancillary products as additional sources of revenue.
Advertisement
Related to this article
Experts look ahead to new maternal vaccines and how to counsel patients on receiving several in one pregnancy.
Experts discuss common patient concerns about vaccination in pregnancy and strategies to improve uptake.
Experts discuss how obstetric and pediatric clinicians can coordinate to protect newborns.
Experts review ACOG's 2026-27 guidance and the RSV window extension for pregnant and postpartum patients.
On September 9, 2026, certolizumab pegol received FDA Breakthrough Therapy Designation for APS pregnancy; Jane E. Salmon, MD, reviews the IMPACT trial results behind it.
SUID was the largest single contributor to the Black-White infant mortality gap in 2024 and drove the biggest share of its rise since 2020.
Garima Sharma, MD, outlines validated cardiac risk scores for antenatal screening and the postpartum transitions needed to keep high-risk patients from being lost to follow-up.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
TMS 2026: HSDD biopsychosocial approach, night sweats red flags, misread WHI data
2
Neurokinin receptor antagonists improve menopausal sleep disturbance
3
Higher physical activity tied to lower perimenopause symptom burden
4
How misread WHI data reshaped menopause care and training
5